EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy

Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Chen iD, Sheng Wang

Angewandte Chemie International Edition · 28.07.2025 · 64 (31)

DOI: 10.1002/anie.202507702 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 18.06.2025. Verfasst von Xu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P.R. China. Hauptthemen laut MEDLINE: Proteolysis, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 198 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation, which aims to eliminate dysregulated proteins, has emerged as a promising strategy for conquering challenging therapeutic targets. Proteolysis‐targeting chimera (PROTAC) is a heterobifunctional molecule that utilizes the ubiquitin‐proteasome system to selectively degrade target proteins. Due to its ability to degrade “undruggable” proteins without causing drug resistance, PROTAC has shown great potential in innovative drug development, especially in cancer therapy. However, conventional PROTACs suffer from several limitations, such as limited solubility, poor permeability, hook effect, and off‐target toxicity. Therefore, structural innovation of conventional PROTACs to make them meet the therapeutic demand is essential for unlocking the full potential of PROTACs as a therapeutic tool. Here, we summarize four types of unconventional PROTACs for addressing the above challenges and enhancing cancer therapy efficacy, including PROTACs with unconventional binding ligands, PROTACs with unconventional linkers, pro‐PROTACs, and self‐assembled PROTACs. These optimized designs contribute to the development of PROTACs‐based universal platforms, providing directions for innovative drug developments and expanding the applications of PROTACs in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisNeoplasmsAntineoplastic AgentsHumansProteasome Endopeptidase ComplexProteolysis Targeting Chimera

Stichwörter der Autor:innen

Cancer therapyNanomaterialPROTACProdrugProtein regulation

Substanzen

Antineoplastic AgentsProteasome Endopeptidase ComplexProteolysis Targeting Chimera

Autor:innen und Institutionen

  • School of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin, 300072, P.R. China.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 138667, Singapore.
  • Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, 100084, P.R. China.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • China Postdoctoral Science Foundation
  • National University of Singapore
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, X., Song, Z., Zhang, X., Zou, J., Yu, G., Chen, X., & Wang, S. (2025). Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy. Angewandte Chemie International Edition, 64(31). https://doi.org/10.1002/anie.202507702

Vancouver

Zhang X, Song Z, Zhang X, Zou J, Yu G, Chen X, et al. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy. Angewandte Chemie International Edition. 2025;64(31). doi:10.1002/anie.202507702

BibTeX
@article{Zhang2025,
  author = {Zhang, Xu and Song, Zhangzhi and Zhang, Xinyu and Zou, Jianhua and Yu, Guocan and Chen, Xiaoyuan and Wang, Sheng},
  title = {Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  volume = {64},
  number = {31},
  doi = {10.1002/anie.202507702}
}
Kostenlos starten →